Skip to content
Sufenta preservative free, Zalviso(sufentanil)
Dsuvia, Dzuveo, Sufenta (sufentanil) is a small molecule pharmaceutical. Sufentanil was first approved as Sufenta preservative free on 1984-05-04. It is used to treat pain in the USA. It has been approved in Europe to treat pain and postoperative pain. The pharmaceutical is active against mu-type opioid receptor.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Dsuvia, Sufenta (generic drugs available since 1995-12-15)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sufentanil citrate
Tradename
Company
Number
Date
Products
SUFENTA PRESERVATIVE FREEAkornN-019050 RX1984-05-04
1 products, RLD, RS
DSUVIAVertical PharmaceuticalsN-209128 RX2018-11-02
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
dsuviaNew Drug Application2019-10-10
sufentanil citrateNew Drug Application2022-02-04
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
painEFO_0003843D010146R52
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Sufentanil Citrate, Dsuvia, Vertical Pharms
89455922031-07-29DP
82025352030-10-22U-1351
88657432030-10-22U-1351
85741892030-03-16DP
108967512030-03-16DP
82269782027-01-05DPU-1351
82319002027-01-05DP
82523282027-01-05DP
82523292027-01-05DP
85357142027-01-05DPU-1351
87783932027-01-05U-1351
87783942027-01-05U-1351
88652112027-01-05U-1351
93207102027-01-05U-1351
97441292027-01-05DP
102452282027-01-05DPU-1351
103427622027-01-05DP
105071802027-01-05DPU-1351
ATC Codes
N: Nervous system drugs
— N01: Anesthetics
— N01A: Anesthetics, general
— N01AH: Opioid anesthetics
— N01AH03: Sufentanil
HCPCS
No data
Clinical
Clinical Trials
198 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149G89.18—2712526
PainD010146EFO_0003843R5215110419
AnesthesiaD000758—134917
AnalgesiaD000698——24410
Acute painD059787R52—145—10
Labor painD048949——2248
Chronic painD059350HP_0012532—1—3—4
Patient-controlled analgesiaD016058———4—4
General anesthesiaD000768——1214
Postoperative nausea and vomitingD020250EFO_0004888———123
Show 30 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver diseasesD008107EFO_0001421K70-K77—11—23
Healthy volunteers/patients—221——3
Nerve blockD009407——1—12
Spinal fusionD013123——1—12
Drug-related side effects and adverse reactionsD064420T88.7——1—12
PremedicationD011292—22——2
Intratracheal intubationD007442—22——2
Inflammatory bowel diseasesD015212EFO_0003767—11——1
LaparoscopyD010535——1——1
Back painD001416HP_0003418M54——1——1
Show 6 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C80—1——12
Prenatal diagnosisD011296—1———1
Craniocerebral traumaD006259S00—1———1
PulpitisD011671EFO_1001139K04.0—1———1
AnxietyD001007EFO_0005230F41.1—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD0105992————2
Biological availabilityD0016821————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Replacement arthroplasty kneeD019645————22
BradycardiaD001919HP_0001662R00.1————11
MelanomaD008545————11
Pancreatic neoplasmsD010190EFO_0003860C25————11
Fertilization in vitroD005307————11
Hallux valgusD006215HP_0001822————11
DiseaseD004194EFO_0000408R69————11
SpondylolisthesisD013168EFO_0007493M43.1————11
Pregnancy outcomeD011256————11
Wounds and injuriesD014947T14.8————11
Show 14 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSUFENTANIL
INNsufentanil
Description
Sufentanil is an anilide resulting from the formal condensation of the aryl amino group of 4-(methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]piperidin-4-amine with propanoic acid. It has a role as an opioid analgesic, a mu-opioid receptor agonist, an anaesthesia adjuvant and an intravenous anaesthetic. It is a member of piperidines, a member of thiophenes, an anilide and an ether.
Classification
Small molecule
Drug classnarcotic analgesics (fentanyl derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1
Identifiers
PDB—
CAS-ID56030-54-7
RxCUI56795
ChEMBL IDCHEMBL658
ChEBI ID9316
PubChem CID41693
DrugBankDB00708
UNII IDAFE2YW0IIZ (ChemIDplus, GSRS)
Target
Agency Approved
OPRM1
OPRM1
Organism
Homo sapiens
Gene name
OPRM1
Gene synonyms
MOR1
NCBI Gene ID
4988
Protein name
mu-type opioid receptor
Protein synonyms
hMOP, MOP, Mu opiate receptor, Mu opioid receptor, mu opioid receptor hMOR-1a
Uniprot ID
Q9UN57
Mouse ortholog
Oprm1 (18390)
mu-type opioid receptor (P42866)
Alternate
No data
Variants
Clinical Variant
No data
Financial
Dzuveo - AcelRx Pharmaceuticals
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Dsuvia - AcelRx Pharmaceuticals
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Zalviso - AcelRx Pharmaceuticals
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 174 documents
View more details
Safety
Black-box Warning
Black-box warning for: Dsuvia, Sufentanil citrate
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
13 adverse events reported
View more details